Professor Kim’s specialty is medical treatment of lung cancer. As a member of the Seoul National University Cancer Research Institute, he carries out researches to identify predictive factors and resistance mechanisms of anti-cancer drugs for patients with lung cancer. Also, he has extensive experience in conducting clinical trials including early phase clinical studies with molecular targeted agents.
